학술논문
Safety and Efficacy of Ritlecitinib and Brepocitinib in Alopecia Areata: Results from the Crossover Open-Label Extension of the ALLEGRO Phase 2a Trial
Document Type
Article
Author
Source
In JID Innovations November 2022 2(6)
Subject
Language
ISSN
2667-0267